Clinical trial
Post Marketing Surveillance of Safety and Efficacy for Cholib® in Korean Patients Under the "New Drug Re-examination".
NCT02489331 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Marketing Surveillance of Safety and Efficacy for Cholib® in Korean Patients Under the "New Drug Re-examination".
- Lead sponsor
- Abbott
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2015
- Completion date
- November 10, 2020
- Enrollment
- 193 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.